Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

News from ADA

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    News from ADA. Pharmacoecon. Outcomes News 633, 4–5 (2011). https://doi.org/10.2165/00151234-201106330-00008

    Download citation

    Keywords

    • Chronic Kidney Disease
    • Metformin
    • American Diabetes Association
    • Glipizide
    • Insulin Lispro